From these data, it appears that SJS/TEN is far less prevalent following administration of ACE inhibitors than allopurinol, as only 44/379 (11.6%) patients in the study taking ACE inhibitors developed SJS/TEN [58]. This evidence concerns the gene ACE and Schwartz-Jampel syndrome.